|
|
|
|
Intracoronary administration of allogeneic adipose tissue-derived mesenchymal stem cells improves myocardial perfusion but not left ventricle function,in a translational model of acute myocardial infarction
|
|
|
|
|
|
|
|
نویسنده
|
bobi j. ,solanes n. ,fernández-jiménez r. ,galán-arriola c. ,dantas a.p. ,fernández-friera l. ,gálvez-montón c. ,rigol-monzó e. ,agüero j. ,ramírez j. ,roqué m. ,bayés-genís a. ,sánchez-gonzález j. ,garcía-álvarez a. ,sabaté m. ,roura s. ,ibáñez b. ,rigol m.
|
|
منبع
|
journal of the american heart association - 2017 - دوره : 6 - شماره : 5
|
|
چکیده
|
Background- autologous adipose tissue-derived mesenchymal stem cells (atmscs) therapy is a promising strategy to improve post-myocardial infarction outcomes. in a porcine model of acute myocardial infarction,we studied the long-term effects and the mechanisms involved in allogeneic atmscs administration on myocardial performance. methods and results- thirty-eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. after reperfusion,allogeneic atmscs or culture medium (vehicle) were intracoronarily administered. follow-ups were performed at short (2 days after acute myocardial infarction vehicle-treated,n=10; atmscs-treated,n=9) or long term (60 days after acute myocardial infarction vehicle-treated,n=7; atmscs-treated,n=7). at short term,infarcted myocardium analysis showed reduced apoptosis in the atmscs-treated animals (48.6±6% versus 55.9±5.7% in vehicle; p=0.017); enhancement of the reparative process with up-regulated vascular endothelial growth factor,granulocyte macrophage colony-stimulating factor,and stromal-derived factor-1a gene expression; and increased m2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; p=0.016). in long-term groups,increase in myocardial perfusion at the anterior infarct border was observed both on day-7 and day-60 cardiac magnetic resonance studies in atmscs-treated animals,compared to vehicle (87.9±28.7 versus 57.4±17.7 ml/min per gram at 7 days; p=0.034 and 99±22.6 versus 43.3±14.7 22.6 ml/min per gram at 60 days; p=0.0001,respectively). at day 60,higher vascular density was detected at the border zone in the atmscs-treated animals (118±18 versus 92.4±24.3 vessels/mm2 in vehicle; p=0.045). cardiac magnetic resonance-measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. conclusions- in this porcine acute myocardial infarction model,allogeneic atmscs-based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance-measured perfusion. no effect on left ventricular volumes or ejection fraction was observed. © 2017 the authors.
|
|
کلیدواژه
|
Adipose tissue-derived mesenchymal stem cells; Allogeneic origin; Myocardial infarction; Myocardial perfusion; Vascular density
|
|
آدرس
|
august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain, centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid,spain,icahn school of medicine at mount sinai,new york,ny,united states,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain, centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid,spain,hospital universitario hm montepríncipe,madrid,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, icrec research program,health science research institute germans trias i pujol,badalona,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, servei d'immunologia, Spain, centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid,spain,ciber de enfermedades cardiovasculares (cibercv),madrid,spain,cardiology department,hospital universitari i politecnic la fe,valencia, Spain, servei d'anatomia patològica, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain, icrec research program,health science research institute germans trias i pujol,badalona,spain,hospital clínic de barcelona,barcelona,spain,cardiology service,germans trias i pujol university hospital,badalona,spain,department of medicine,universitat autònoma de barcelona (uab),barcelona,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, philips healthcare,madrid, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona,spain,centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain, icrec research program,health science research institute germans trias i pujol,badalona,spain,center of regenerative medicine in barcelona,barcelona,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, centro nacional de investigaciones cardiovasculares carlos iii,cnic,madrid,spain,iis- fundación jiménez díaz hospital,madrid,spain,ciber de enfermedades cardiovasculares (cibercv),madrid, Spain, august pi i sunyer biomedical research institute (idibaps),institut de malalties cardiovasculars,hospital clínic de barcelona,universitat de barcelona, Spain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|